| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1997PNAS...94..610D |
| P356 | DOI | 10.1073/PNAS.94.2.610 |
| P932 | PMC publication ID | 19561 |
| P698 | PubMed publication ID | 9012832 |
| P5875 | ResearchGate publication ID | 24450592 |
| P2093 | author name string | Grosveld F | |
| Savelkoul HF | |||
| De Wit TP | |||
| Dingjan GM | |||
| Drabek D | |||
| Hendriks RW | |||
| Raguz S | |||
| P2860 | cites work | Binding of Bruton's tyrosine kinase to Fyn, Lyn, or Hck through a Src homology 3 domain-mediated interaction | Q24564184 |
| Temporal differences in the activation of three classes of non-transmembrane protein tyrosine kinases following B-cell antigen receptor surface engagement | Q28615625 | ||
| B-cell antigen receptor stimulation activates the human Bruton's tyrosine kinase, which is deficient in X-linked agammaglobulinemia | Q28615845 | ||
| BTKbase, mutation database for X-linked agammaglobulinemia (XLA). | Q30192775 | ||
| IL-5 receptor-mediated tyrosine phosphorylation of SH2/SH3-containing proteins and activation of Bruton's tyrosine and Janus 2 kinases | Q30193880 | ||
| Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia | Q30195143 | ||
| The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases | Q34355151 | ||
| Vertebrate non-receptor protein-tyrosine kinase families | Q34425007 | ||
| Far upstream regions of class II MHC Ea are necessary for position-independent, copy-dependent expression of Ea transgene | Q34981826 | ||
| Bruton tyrosine kinase is tyrosine phosphorylated and activated in pre-B lymphocytes and receptor-ligated B cells | Q35864977 | ||
| Inactivation of Btk by insertion of lacZ reveals defects in B cell development only past the pre-B cell stage | Q35908626 | ||
| Sequences and factors: a guide to MHC class-II transcription | Q36135151 | ||
| Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow | Q36230070 | ||
| Unbalanced X chromosome mosaicism in B cells of mice with X-linked immunodeficiency | Q36348127 | ||
| Development of B lymphocytes in mice heterozygous for the X-linked immunodeficiency (xid) mutation. xid inhibits development of all splenic and lymph node B cells at a stage subsequent to their initial formation in bone marrow | Q36353541 | ||
| The CBA/N mouse strain: an experimental model illustrating the influence of the X-chromosome on immunity. | Q40113569 | ||
| Molecular and cellular aspects of X-linked agammaglobulinemia. | Q40373279 | ||
| B-cell differentiation in the bone marrow and the periphery. | Q40673776 | ||
| Bruton's tyrosine kinase is a key regulator in B-cell development | Q40694860 | ||
| X-linked agammaglobulinemia: new approaches to old questions based on the identification of the defective gene. | Q40694880 | ||
| X-linked agammaglobulinemia (XLA): a genetic tyrosine kinase (Btk) disease | Q41182308 | ||
| Defective B cell development and function in Btk-deficient mice | Q41306033 | ||
| Association and activation of Btk and Tec tyrosine kinases by gp130, a signal transducer of the interleukin-6 family of cytokines | Q41378321 | ||
| The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages | Q41510794 | ||
| Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice | Q41541610 | ||
| B lymphocyte production in the bone marrow of mice with X-linked immunodeficiency (xid). | Q44969200 | ||
| Prolonged in vivo IL-4 treatment inhibits antigen-specific IgG1 and IgE formation. | Q52057514 | ||
| Aberrant B Cell Development and Immune Response in Mice with a Compromised BCR Complex | Q57198357 | ||
| B-cell subpopulations identified by two-colour fluorescence analysis | Q59095894 | ||
| Expression of the gene defect in X-linked agammaglobulinemia | Q68802596 | ||
| Demonstration of B-cell maturation in X-linked immunodeficient mice by simultaneous three-colour immunofluorescence | Q70303278 | ||
| Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67 | Q72743242 | ||
| Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes | Q72835320 | ||
| P4510 | describes a project that uses | ImageQuant | Q112270642 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | phenotype | Q104053 |
| P304 | page(s) | 610-615 | |
| P577 | publication date | 1997-01-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Correction of the X-linked immunodeficiency phenotype by transgenic expression of human Bruton tyrosine kinase under the control of the class II major histocompatibility complex Ea locus control region | |
| P478 | volume | 94 |
| Q43826446 | A Btk transgene restores the antiviral TI-2 antibody responses of xid mice in a dose-dependent fashion |
| Q38161559 | Agammaglobulinemia: causative mutations and their implications for novel therapies |
| Q33747337 | B cell-specific lentiviral gene therapy leads to sustained B-cell functional recovery in a murine model of X-linked agammaglobulinemia |
| Q38581000 | BTK Signaling in B Cell Differentiation and Autoimmunity |
| Q45050515 | Bi-directional regulation between tyrosine kinase Etk/BMX and tumor suppressor p53 in response to DNA damage |
| Q36720312 | Btk dosage determines sensitivity to B cell antigen receptor cross-linking |
| Q40005186 | Development of an enhanced B-specific lentiviral vector expressing BTK: a tool for gene therapy of XLA. |
| Q38988830 | Enhanced Bruton's Tyrosine Kinase Activity in Peripheral Blood B Lymphocytes From Patients With Autoimmune Disease |
| Q77174555 | Genetic basis of abnormal B cell development |
| Q73149913 | Modulation by Anapsos (Polypodium leucotomos extract) of the antibody responses against the nematode parasite Trichinella spiralis |
| Q45862082 | Murine MHC class II locus control region drives expression of human beta-glucocerebrosidase in antigen presenting cells of transgenic mice |
| Q33889470 | Severe B cell deficiency and disrupted splenic architecture in transgenic mice expressing the E41K mutated form of Bruton's tyrosine kinase |
| Q38198490 | Targeting Bruton's tyrosine kinase in B cell malignancies |
| Q73814849 | The X-linked immunodeficiency defect in the mouse is corrected by expression of human Bruton's tyrosine kinase from a yeast artificial chromosome transgene |
| Q53144072 | The effect of glycosylation of antigens on the antibody responses against Echinostoma caproni (Trematoda: Echinostomatidae). |
| Q34099457 | X-linked agammaglobulinemia |
Search more.